Atrium Therapeutics, Inc.
corporate_fare Company Profile
Atrium Therapeutics, Inc. (NASDAQ:RNA) is a publicly traded company in the Healthcare sector. Wiseek monitors RNA SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Atrium Therapeutics Reports Strong Q1 Cash Position of $267.8M, $19.6M Collaboration Revenue Post-Spin-Off
- Atrium Therapeutics Reports First Q1 Results as Independent Company with Strong Cash Position and $15M Milestone
- Atrium Therapeutics Reports Strong Q1 with $15M BMS Milestone and $268M Cash
- Avidity Biosciences Completes $72.00/Share Acquisition by Novartis AG; Spin-Off of Atrium Therapeutics Finalized, Delisting Imminent
- Novartis Finalizes Avidity Biosciences Acquisition; Shareholders to Receive $72 Cash Per Share
show_chartPrice Chart
Loading chart...
feed RNA - Latest Insights
RNA
May 14, 2026, 4:53 PM EDT
Price at Filing:
$13.27
Real-time Price:
$12.37
Change:
-$0.900 (-7%)
Market Cap:
$211.597M
RNA
May 14, 2026, 4:51 PM EDT
Price at Filing:
$13.27
Real-time Price:
$12.37
Change:
-$0.900 (-7%)
Market Cap:
$211.597M
RNA
May 14, 2026, 4:50 PM EDT
Price at Filing:
$13.27
Real-time Price:
$12.37
Change:
-$0.900 (-7%)
Market Cap:
$211.597M
RNA
Feb 27, 2026, 9:13 AM EST
Price at Filing:
$15.30
Real-time Price:
$12.37
Change:
-$2.93 (-19%)
Market Cap:
$211.597M
RNA
Feb 27, 2026, 9:03 AM EST
Price at Filing:
$15.24
Real-time Price:
$12.37
Change:
-$2.87 (-19%)
Market Cap:
$211.597M
RNA
Feb 26, 2026, 4:58 PM EST
Price at Filing:
$72.77
Real-time Price:
$12.37
Change:
-$60.40 (-83%)
Market Cap:
$211.597M
RNA
Feb 23, 2026, 4:04 PM EST
Avidity Biosciences Details Novartis Merger, Spin-Off, and Strong Clinical Progress in Annual Report
Price at Filing:
$72.92
Real-time Price:
$12.37
Change:
-$60.55 (-83%)
Market Cap:
$211.597M
RNA
Feb 23, 2026, 8:30 AM EST
Price at Filing:
$72.86
Real-time Price:
$12.37
Change:
-$60.49 (-83%)
Market Cap:
$211.597M
RNA
Feb 18, 2026, 8:51 AM EST
Price at Filing:
$72.93
Real-time Price:
$12.37
Change:
-$60.56 (-83%)
Market Cap:
$211.597M
RNA
Feb 13, 2026, 4:15 PM EST
Avidity Biosciences Files Merger Supplement, Discloses New Shareholder Lawsuits, and ROFN Expiration
Price at Filing:
$72.70
Real-time Price:
$12.37
Change:
-$60.33 (-83%)
Market Cap:
$211.597M
RNA
Feb 03, 2026, 7:00 AM EST
Price at Filing:
$72.74
Real-time Price:
$12.37
Change:
-$60.37 (-83%)
Market Cap:
$211.597M
RNA
Jan 30, 2026, 4:37 PM EST
Price at Filing:
$72.57
Real-time Price:
$12.37
Change:
-$60.20 (-83%)
Market Cap:
$211.597M
RNA
Jan 14, 2026, 4:01 PM EST
Price at Filing:
$72.54
Real-time Price:
$12.37
Change:
-$60.17 (-83%)
Market Cap:
$211.597M
RNA
Jan 12, 2026, 4:35 PM EST
Price at Filing:
$72.35
Real-time Price:
$12.37
Change:
-$59.98 (-83%)
Market Cap:
$211.597M
RNA
Jan 12, 2026, 4:30 PM EST
Price at Filing:
$72.35
Real-time Price:
$12.37
Change:
-$59.98 (-83%)
Market Cap:
$211.597M